Miranda Brouwer

Datos Biográficos

ID7757344
NOMBREMiranda Brouwer
NOMBRESMiranda
APELLIDOBrouwer
FIRMABROUWER M
AFILIACIONESHealth Alliance International
ORCID0000-0001-8260-4649
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2012
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Engaging private providers to enhance tuberculosis detection and notification

    Open AccessMd Toufiq Rahman, William A Wells et al.ARTICLEBMC Public Health2025

    Our findings suggest that structured and targeted PPE enhances TB case finding and contribute in closing the gap of missing cases. These results emphasize the need for wider implementation and scale-up of PPE in the TB response

  • Finding the missing millions

    Open AccessTripti Pande, Nathaly Aguilera Vasquez et al.ARTICLEBMJ Global Health2020

    box In 2019, 10.0 million people developed tuberculosis (TB) yet 2.9 million were not notified to National TB programmes (NTPs).1 This is largely due to limited accessibility to healthcare services, underdeveloped health reporting systems, insufficient human resources and poor linkages between private providers and national authorities.2 There are various global initiatives to address this challenge, including the Find.Treat.All #EndTB initiative…

  • Tuberculosis retreatment ‘others’ in comparison with classical retreatment cases; a retrospective cohort review

    Open AccessMary G Nabukenya-Mudiope, H J S Kawuma et al.ARTICLEBMC Public Health2015

    TB retreatment 'others' constitute a significant proportion of retreatment cases, with higher HIV prevalence and worse treatment success. There is need to review the diagnosis and management of retreatment 'others

  • The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique

    Open AccessMiranda Brouwer, Paula Samu Gudo et al.ARTICLEBMC Public Health2012

    In this study, no independent effect of TB treatment on CD4+ cell count was found. HIV-infected TB patients on ART had a significantly higher CD4+ cell count than those not receiving ART. CD4+ cell counts for patients not on ART at TB treatment start, remained below the cut off for initiating ART during the first three months of TB treatment; therefore some delay in getting the first CD4+ cell count would not lead to missing the opportunity to st…